The Characterization & Aggregation in Biopharmaceuticals pipeline features two back-to-back popular conferences addressing critical topics such as analytical and characterization tools for protein formulation development, aggregation, stability assessment, and impurities in biotherapeutics and vaccines. These conferences will feature case studies, new and unpublished data, interactive panel discussions, keynote talks, and many opportunities to network and make connections to discuss the timeliest issues and opportunities in biotherapeutics development.
Characterization of Biotherapeutics
Characterizing Protein Aggregates and Impurities
KEYNOTE & FEATURED PRESENTATIONS:
Connecting the Lab to the Machine: A Retrospective Analysis and Prospective Evaluation
Michael S. Marlow, PhD, Director Biologics CMC Research, Biotherapeutics Discovery, Boehringer Ingelheim Pharmaceuticals, Inc.
Frozen State Protein Aggregation and Its Impact on Biologic Process Development
Bharat Jagannathan, PhD, Principal Scientist, Attribute Sciences, Amgen Inc.
The Role of Interactome in Host Cell Protein Composition in Downstream Processing
Alois Jungbauer, PhD, Professor & Head, Biotechnology, Institute of Bioprocess Science and Engineering, University of Natural Resources and Life Sciences (BOKU)
If you are working in the following areas join the PepTalk community:
New Product Development
Formulation and Drug Delivery
Process & Product Development
(New) Product Development
Protein Analytical Chemistry
Purification and Process Development
Research & Development
Biotherapeutics Research & Development
Manufacturing, Science & Technologies